Wilhelmus Cm Groenhuysen, Chief Operating Officer at NovoCure Ltd (NVCR), sold 97,636 shares at $99.33 ($10.0M) on 2020-09-15, disclosed to the SEC on 2020-09-16.
Open-market sale of $10.0M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.01 | 12,500 | $1.2M | 12.2% |
| 2 | $98.48 | 1,900 | $187K | 1.9% |
| 3 | $98.50 | 1,900 | $187K | 1.9% |
| 4 | $99.33 | 2,200 | $219K | 2.2% |
| 5 | $99.33 | 2,197 | $218K | 2.2% |
| 6 | $99.33 | 2,197 |
| $218K |
| 2.2% |
| 7 | $100.27 | 1,100 | $110K | 1.1% |
| 8 | $100.28 | 1,100 | $110K | 1.1% |
| 9 | $101.19 | 1,207 | $122K | 1.2% |
| 10 | $101.19 | 1,207 | $122K | 1.2% |
| 11 | $101.20 | 1,200 | $121K | 1.2% |
| 12 | $102.55 | 1,200 | $123K | 1.2% |
| 13 | $102.58 | 1,200 | $123K | 1.2% |
| 14 | $103.75 | 1,700 | $176K | 1.8% |
| 15 | $103.76 | 1,800 | $187K | 1.9% |
| 16 | $104.45 | 13,368 | $1.4M | 13.9% |
| 17 | $104.45 | 13,368 | $1.4M | 13.9% |
| 18 | $104.53 | 2,203 | $230K | 2.3% |
| 19 | $104.53 | 2,203 | $230K | 2.3% |
| 20 | $104.55 | 2,193 | $229K | 2.3% |
| 21 | $104.55 | 2,193 | $229K | 2.3% |
| 22 | $104.69 | 10,166 | $1.1M | 10.6% |
| 23 | $104.69 | 10,166 | $1.1M | 10.6% |
| 24 | $105.53 | 700 | $74K | 0.7% |
| 25 | $105.54 | 600 | $63K | 0.6% |
| 26 | $105.54 | 600 | $63K | 0.6% |
| 27 | $106.02 | 2,334 | $247K | 2.5% |
| 28 | $106.02 | 2,334 | $247K | 2.5% |
| 29 | $106.33 | 300 | $32K | 0.3% |
| 30 | $106.39 | 300 | $32K | 0.3% |
| Total | $102.93 avg | 97,636 | $10.0M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |